Labland Biotechs
Labland Biotechs is a Private Indian company incorporated in 1994 and based in Karnataka, India. Labland Biotechs operates in Pharmaceuticals & Chemicals (NIC 24129) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.
Labland Biotechs - Provider of tissue culture and plantlets. Raised a total funding of $32.9K over 2 rounds from 52 investors.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Labland Biotechs.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +37d | filed |
| MGT-7 | FY2024-25 | 21 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +20d | filed |
| MGT-7 | FY2023-24 | 26 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 23 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Labland Biotechs.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 942092077 | Kotak Mahindra Bank Ltd(Bank) | ₹14.15 Cr | 19 Sep 2020 | Open |
| 748053306 | Axis Bank Ltd(Bank) | ₹18.83 Cr | 12 Mar 2020 | Open |
| 996249968 | Axis Bank Ltd(Bank) | ₹14.91 Cr | 19 Sep 2020 | Satisfied |
| 910780414 | Kotak Mahindra Bank Ltd(Bank) | ₹6.40 Cr | 27 Jan 2021 | Satisfied |
| 747409279 | ICICI Bank Ltd(Bank) | ₹22.53 Cr | 04 Jul 2019 | Open |
| 139029649 | Axis Bank Ltd(Bank) | ₹3.85 Cr | 27 Jan 2019 | Open |
Charge IDs, lenders & amounts for Labland Biotechs.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹76.96 Cr | ₹2.23 Cr | ₹54.27 Cr | ₹117.29 Cr | 250 |
| FY2023-24 | ₹68.68 Cr | ₹2.32 Cr | ₹39.13 Cr | ₹78.00 Cr | 85 |
| FY2022-23 | ₹62.43 Cr | ₹2.75 Cr | ₹47.18 Cr | ₹95.66 Cr | 42 |
| FY2021-22 | ₹42.73 Cr | ₹2.25 Cr | ₹14.57 Cr | ₹42.49 Cr | 109 |
Audited financials & ratios for Labland Biotechs.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹76.96 Cr | ₹68.68 Cr | ₹62.43 Cr | ₹42.73 Cr |
| Other income | ₹1.37 Cr | ₹36.48 L | ₹2.13 Cr | ₹83.46 L |
| Total income | ₹78.33 Cr | ₹69.05 Cr | ₹64.56 Cr | ₹43.57 Cr |
| Total expenses | ₹75.47 Cr | ₹66.09 Cr | ₹61.04 Cr | ₹40.68 Cr |
| Profit before tax | ₹2.90 Cr | ₹3.01 Cr | ₹3.58 Cr | ₹2.93 Cr |
| Profit / (Loss) after tax | ₹2.23 Cr | ₹2.32 Cr | ₹2.75 Cr | ₹2.25 Cr |
| Balance sheet | ||||
| Equity / Net worth | ₹54.27 Cr | ₹39.13 Cr | ₹47.18 Cr | ₹14.57 Cr |
| Borrowings | ₹26.63 Cr | ₹14.93 Cr | ₹26.05 Cr | ₹11.07 Cr |
| Current liabilities | ₹22.12 Cr | ₹22.11 Cr | ₹19.61 Cr | ₹13.87 Cr |
| Total liabilities | ₹63.02 Cr | ₹38.87 Cr | ₹48.47 Cr | ₹27.93 Cr |
| Current assets | ₹56.36 Cr | ₹36.83 Cr | ₹42.07 Cr | ₹15.16 Cr |
| Cash & equivalents | ₹14.38 Cr | ₹8.34 Cr | ₹5.85 Cr | ₹3.42 Cr |
| Total assets | ₹117.29 Cr | ₹78.00 Cr | ₹95.66 Cr | ₹42.49 Cr |
| Employees | 250 | 85 | 42 | 109 |
Audited financials & ratios for Labland Biotechs.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹76.96 Cr | -0.7% | +17.1% | +17.3% |
| Profit after Tax | ₹2.23 Cr | +13.1% | +22.5% | +14.5% |
| Net Worth | ₹54.27 Cr | -6.5% | +21.9% | +1.9% |
| Employees | 250 | +23.1% | +4.5% | -1.9% |
Audited financials & ratios for Labland Biotechs.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹76.96 Cr | ₹2.23 Cr | +2.90% | +31.54% | +4.11% | +1.90% | 0.49 | ₹30.78 L |
| FY2023-24 | ₹68.68 Cr | ₹2.32 Cr | +3.37% | -13.69% | +5.92% | +2.97% | 0.38 | ₹80.81 L |
| FY2022-23 | ₹62.43 Cr | ₹2.75 Cr | +4.41% | +35.53% | +5.83% | +2.87% | 0.55 | ₹1.49 Cr |
| FY2021-22 | ₹42.73 Cr | ₹2.25 Cr | +5.27% | +28.98% | +15.46% | +5.30% | 0.76 | ₹39.20 L |
Audited financials & ratios for Labland Biotechs.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 1 | 3,21,89,909 | 65.52% |
| Institutional Investors | 3 | 41,17,013 | 8.38% |
| Public & Others | 8 | 1,28,25,008 | 26.10% |
Promoter, institutional & public holding for Labland Biotechs.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
7 peersExternal data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.